Biotricity (BTCY) Stock Statistics & Valuation Metrics

Biotricity has a market cap or net worth of $2.14M. The enterprise value is $35.42.

Biotricity has 20,074,675 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biotricity’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -37.57%.

The current PE Ratio of Biotricity is ―. Biotricity’s PEG ratio is 0.03.

In the last 12 months, Biotricity had revenue of 16.00M and earned -2.40M in profits. Earnings per share was -0.11.

In the last 12 months, operating cash flow was -718.96K and capital expenditures 5.00, giving a free cash flow of -718.96K billion.

Biotricity pays an annual dividend of ―, resulting in a dividend yield of ―

Biotricity upcoming earnings date is Aug 17, 2026, Before Open (Confirmed).

Biotricity as a current ratio of 0.16, with Debt / Equity ratio of -75.53%

In the past 12 months, Biotricity has paid 0.00 in taxes.

Biotricity EV to EBITDA ratio is 19.72, with an EV/FCF ratio of -46.40.

Biotricity has $149.79K in cash and marketable securities with $27.06M in debt, giving a net cash position of -$26.91M billion.

Gross margin is 81.09%, with operating margin of 10.57%, and net profit margin of -15.03%.

The average price target for Biotricity is ―, which is 11.43% higher than the current price. The consensus rating is ―